| Cancer | ID | Symbol | Immune Pathway | P value | FDR value | ES value | Score | number |
|---|---|---|---|---|---|---|---|---|
| SARC | ENSG00000126012 | KDM5C | TCR signaling Pathway | 1.923e-03 | 1.638e-02 | 0.4591 | 0.9962 | 37 |
| SARC | ENSG00000126012 | KDM5C | TGFb Family Member | 1.927e-03 | 1.638e-02 | 0.5751 | 0.9961 | 13 |
| SARC | ENSG00000161091 | MFSD12 | Antigen Processing and Presentation | 1.916e-03 | 3.257e-02 | 0.4795 | 0.9962 | 41 |
| SARC | ENSG00000179344 | HLA-DQB1 | Antigen Processing and Presentation | 1.524e-03 | 9.214e-03 | 0.5859 | 0.997 | 52 |
| SARC | ENSG00000179344 | HLA-DQB1 | Antimicrobials | 1.332e-03 | 9.214e-03 | 0.3798 | 0.9973 | 98 |
| SARC | ENSG00000179344 | HLA-DQB1 | TCR signaling Pathway | 1.626e-03 | 9.214e-03 | 0.5421 | 0.9967 | 32 |
| SARC | ENSG00000232629 | HLA-DQB2 | Antigen Processing and Presentation | 1.684e-03 | 9.924e-03 | 0.6632 | 0.9966 | 38 |
| SARC | ENSG00000232629 | HLA-DQB2 | Antimicrobials | 1.546e-03 | 9.924e-03 | 0.4348 | 0.9969 | 85 |
| SARC | ENSG00000232629 | HLA-DQB2 | TCR signaling Pathway | 1.751e-03 | 9.924e-03 | 0.5756 | 0.9965 | 26 |
| SARC | ENSG00000198502 | HLA-DRB5 | Antigen Processing and Presentation | 1.522e-03 | 6.789e-03 | 0.6406 | 0.997 | 51 |
| SARC | ENSG00000198502 | HLA-DRB5 | Antimicrobials | 1.305e-03 | 6.789e-03 | 0.4464 | 0.9974 | 112 |
| SARC | ENSG00000198502 | HLA-DRB5 | Natural Killer Cell Cytotoxicity | 1.522e-03 | 6.789e-03 | 0.559 | 0.997 | 35 |
| SARC | ENSG00000198502 | HLA-DRB5 | TCR signaling Pathway | 1.597e-03 | 6.789e-03 | 0.5516 | 0.9968 | 32 |